Atoltivimab, Maftivimab, And Odesivimab-Ebgn (Intravenous Route) Description and Brand Names

COVID-19: Advice, updates and vaccine options

Drug information provided by: IBM Micromedex

Atoltivimab, maftivimab, and odesivimab-ebgn combination injection is used to treat infection cause by Zaire ebolavirus.

This medicine is to be given only by or under the direct supervision of your doctor.

Portions of this document last updated: Feb. 01, 2022

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.